Article info

Download PDFPDF
AB0266 Treat-To-Target Biologic Therapy in Patients with Rheumatoid Arthritis Has A Safer Profile Compared To Delayed Initiation of Biologics

Authors

Citation

Lampropoulos C, Orfanos P, Manoussakis M, et al
AB0266 Treat-To-Target Biologic Therapy in Patients with Rheumatoid Arthritis Has A Safer Profile Compared To Delayed Initiation of Biologics

Publication history

  • First published July 15, 2016.
Online issue publication 
July 15, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.